Idera Pharmaceuticals, Inc. (IDRA) Social Stream



Idera Pharmaceuticals, Inc. (IDRA): $0.69

0.00 (-0.01%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add IDRA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 476

in industry

Idera Pharmaceuticals Inc (IDRA) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Idera Pharmaceuticals Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
1 $2 $2 $2 $0.757 164.2%

Price Target Last Issued March 19, 2021

The Trend in the Analyst Price Target


Over the past 52 days, IDRA's average price target has gone down $0.

IDRA reports an average of 28.62% for its upside potential over the past 15 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-08-17 3 1 1 1.0 1.04 -3.85%
2020-05-27 5 10 5 7.6 NA NA%

IDRA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • The number of analysts covering the stock of IDRA is higher than just about none of of all US stocks.
  • Idera Pharmaceuticals Inc's variance in analysts' estimates is less than almost 100% of all US stocks.
  • Idera Pharmaceuticals Inc's average analyst price target is higher than 0.65% of Healthcare stocks.
  • Idera Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 90.35% of all US stocks.

In the Pharmaceutical Products industry, LCI, ADMP and ODT are the three stocks most similar to Idera Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.

Is IDRA a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.653 seconds.